NANOCARRIERBASED THERAPEUTICS AND THERANOSTICS DRUG DELIVERY SYSTEMS FOR NEXT GENERATION OF LIVER CANCER NANODRUG MODALITIES

http://dx.doi.org/10.31703/gpsr.2024(IX-II).03      10.31703/gpsr.2024(IX-II).03      Published : Jun 2024
Authored by : DuaZahid , RabiaTahir , WajihaAshfaq , AbdulWasay , QamerIqbal

03 Pages : 18-29

References

Cite this article

APA

    APA : Zahid, D., Tahir, R., & Ashfaq, W. (2024). Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. Global Pharmaceutical Sciences Review, IX(II), 18-29. https://doi.org/10.31703/gpsr.2024(IX-II).03

CHICAGO

    CHICAGO : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. 2024. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review, IX (II): 18-29 doi: 10.31703/gpsr.2024(IX-II).03

HARVARD

    HARVARD : ZAHID, D., TAHIR, R. & ASHFAQ, W. 2024. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. Global Pharmaceutical Sciences Review, IX, 18-29.

MHRA

    MHRA : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. 2024. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review, IX: 18-29

MLA

    MLA : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review, IX.II (2024): 18-29 Print.

OXFORD

    OXFORD : Zahid, Dua, Tahir, Rabia, and Ashfaq, Wajiha (2024), "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities", Global Pharmaceutical Sciences Review, IX (II), 18-29

TURABIAN

    TURABIAN : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review IX, no. II (2024): 18-29. https://doi.org/10.31703/gpsr.2024(IX-II).03